These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 15150770)
1. Outcomes of systematic screening for optic pathway tumors in children with Neurofibromatosis Type 1. Blazo MA; Lewis RA; Chintagumpala MM; Frazier M; McCluggage C; Plon SE Am J Med Genet A; 2004 Jun; 127A(3):224-9. PubMed ID: 15150770 [TBL] [Abstract][Full Text] [Related]
2. Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing? Wolsey DH; Larson SA; Creel D; Hoffman R J AAPOS; 2006 Aug; 10(4):307-11. PubMed ID: 16935228 [TBL] [Abstract][Full Text] [Related]
3. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients. Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859 [TBL] [Abstract][Full Text] [Related]
4. The Use of Magnetic Resonance Imaging Screening for Optic Pathway Gliomas in Children with Neurofibromatosis Type 1. Prada CE; Hufnagel RB; Hummel TR; Lovell AM; Hopkin RJ; Saal HM; Schorry EK J Pediatr; 2015 Oct; 167(4):851-856.e1. PubMed ID: 26233602 [TBL] [Abstract][Full Text] [Related]
5. Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcome. King A; Listernick R; Charrow J; Piersall L; Gutmann DH Am J Med Genet A; 2003 Oct; 122A(2):95-9. PubMed ID: 12955759 [TBL] [Abstract][Full Text] [Related]
6. Systematic MRI in NF1 children under six years of age for the diagnosis of optic pathway gliomas. Study and outcome of a French cohort. Blanchard G; Lafforgue MP; Lion-François L; Kemlin I; Rodriguez D; Castelnau P; Carneiro M; Meyer P; Rivier F; Barbarot S; Chaix Y; Eur J Paediatr Neurol; 2016 Mar; 20(2):275-281. PubMed ID: 26774135 [TBL] [Abstract][Full Text] [Related]
7. Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of Vision. de Blank PMK; Fisher MJ; Liu GT; Gutmann DH; Listernick R; Ferner RE; Avery RA J Neuroophthalmol; 2017 Sep; 37 Suppl 1(Suppl 1):S23-S32. PubMed ID: 28806346 [TBL] [Abstract][Full Text] [Related]
9. Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. Listernick R; Charrow J; Greenwald M; Mets M J Pediatr; 1994 Jul; 125(1):63-6. PubMed ID: 8021787 [TBL] [Abstract][Full Text] [Related]
10. Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Listernick R; Ferner RE; Liu GT; Gutmann DH Ann Neurol; 2007 Mar; 61(3):189-98. PubMed ID: 17387725 [TBL] [Abstract][Full Text] [Related]
11. Optic Gliomas in Neurofibromatosis Type 1. Parkhurst E; Abboy S J Pediatr Ophthalmol Strabismus; 2016 Nov; 53(6):334-338. PubMed ID: 27537249 [TBL] [Abstract][Full Text] [Related]
12. The role of surgery in optic pathway/hypothalamic gliomas in children. Goodden J; Pizer B; Pettorini B; Williams D; Blair J; Didi M; Thorp N; Mallucci C J Neurosurg Pediatr; 2014 Jan; 13(1):1-12. PubMed ID: 24138145 [TBL] [Abstract][Full Text] [Related]
13. [Long-term outcome of gliomas of the visual pathway in type 1 neurofibromatosis]. Schröder S; Baumann-Schröder U; Hazim W; Haase W; Mautner VF Klin Monbl Augenheilkd; 1999 Dec; 215(6):349-54. PubMed ID: 10637799 [TBL] [Abstract][Full Text] [Related]
14. Feasibility and comparison of visual acuity testing methods in children with neurofibromatosis type 1 and/or optic pathway gliomas. Avery RA; Bouffet E; Packer RJ; Reginald A Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1034-8. PubMed ID: 23329671 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of Strabismus Among Children With Neurofibromatosis Type 1 Disease With and Without Optic Pathway Glioma. Dotan G; Qureshi HM; Toledano-Alhadef H; Azem N; Yahalom C J Pediatr Ophthalmol Strabismus; 2019 Jan; 56(1):19-22. PubMed ID: 30371910 [TBL] [Abstract][Full Text] [Related]
16. Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial UK cohort. Falzon K; Drimtzias E; Picton S; Simmons I Br J Ophthalmol; 2018 Oct; 102(10):1367-1371. PubMed ID: 29343527 [TBL] [Abstract][Full Text] [Related]
17. Neurofibromatosis type 1 and precocious puberty. Virdis R; Sigorini M; Laiolo A; Lorenzetti E; Street ME; Villani AR; Donadio A; Pisani F; Terzi C; Garavelli L J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():841-4. PubMed ID: 10969931 [TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance findings and ophthalmologic abnormalities are correlated in patients with neurofibromatosis type 1 (NF1). Sigorini M; Zuccoli G; Ferrozzi F; Bacchini E; Street ME; Piazza P; Rossi M; Virdis R Am J Med Genet; 2000 Aug; 93(4):269-72. PubMed ID: 10946351 [TBL] [Abstract][Full Text] [Related]
19. [Usefulness of systematic brain magnetic resonance imaging in children with neurofibromatosis type 1]. Blanchard G; Pinson S; Rousselle C; Lorthois S; Combemale P; Bernard M; Lion Francois L Arch Pediatr; 2009 Dec; 16(12):1527-32. PubMed ID: 19864117 [TBL] [Abstract][Full Text] [Related]
20. Optic pathway gliomas in children with and without neurofibromatosis 1. Czyzyk E; Jóźwiak S; Roszkowski M; Schwartz RA J Child Neurol; 2003 Jul; 18(7):471-8. PubMed ID: 12940652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]